AAAAAA

   
Results: 1-8 |
Results: 8
Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium
Authors: Van Vaerenbergh, K Debaisieux, L De Cabooter, N Declercq, C Desmet, K Fransen, K Maes, B Marissens, D Miller, K Muyldermans, G Sprecher, S Stuyver, L Vaira, D Verhofstede, C Zissis, G Van Ranst, M De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70
Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya
Authors: Gaillard, P Mwanyumba, F Verhofstede, C Claeys, P Chohan, V Goetghebeur, E Mandaliya, K Ndinya-Achola, J Temmerman, M
Citation: P. Gaillard et al., Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya, AIDS, 15(3), 2001, pp. 389-396
Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories
Authors: Muyldermans, G Debaisieux, L Fransen, K Marissens, D Miller, K Vaira, D Vandamme, AM Vandenbroucke, AT Verhofstede, C Schuurman, R Zissis, G Lauwers, S
Citation: G. Muyldermans et al., Blinded, multicenter quality control study for the quantification of humanimmunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories, CL MICRO IN, 6(4), 2000, pp. 213-217
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
Authors: Van Vaerenbergh, K Van Laethem, K Van Wijngaerden, E Schmit, JC Schneider, F Ruiz, L Clotet, B Verhofstede, C Van Wanzeele, F Muyldermans, G Simons, P Stuyver, L Hermans, P Evans, C De Clercq, E Desmyter, J Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Exposure to HIV-1 during delivery and mother-to-child transmission
Authors: Gaillard, P Verhofstede, C Mwanyumba, F Claeys, P Chohan, V Mandaliya, K Bwayo, J Plum, J Temmerman, M
Citation: P. Gaillard et al., Exposure to HIV-1 during delivery and mother-to-child transmission, AIDS, 14(15), 2000, pp. 2341-2348
Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype
Authors: Verhofstede, C Van Wanzeele, F Van der Gucht, B De Cabooter, N Plum, J
Citation: C. Verhofstede et al., Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype, AIDS, 13(18), 1999, pp. 2541-2546
Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells
Authors: Verhasselt, B Naessens, E Verhofstede, C De Smedt, M Schollen, S Kerre, T Vanhecke, D Plum, J
Citation: B. Verhasselt et al., Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells, BLOOD, 94(8), 1999, pp. 2809-2818
Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two)
Authors: Fransen, K Mortier, D Heyndrickx, L Verhofstede, C Janssens, W van der Groen, G
Citation: K. Fransen et al., Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two), J VIROL MET, 76(1-2), 1998, pp. 153-157
Risultati: 1-8 |